GlassScriptPhysician profile
Sandra Stahl
NPI 1568962801
$2,280.80
in general payments reported to CMS, 2019-2025
22 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $881 · 2022: $251 · 2023: $523 · 2024: $193 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $889.81 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $283.34 | 2021-2024 | Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.35 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $158.52 | 2021-2023 | Farxiga |
| Inspire Medical Systems, INC. | $137.81 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $87.56 | 2023-2024 | Inpefa |
| Amgen INC. | $70.91 | 2021-2023 | Repatha |
| Scpharmaceuticals INC. | $64.36 | 2024-2025 | |
| Medtronic, INC. | $51.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $42.14 | 2023-2025 | |
| Pfizer INC. | $41.21 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.55 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.07 | 2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $34.95 | 2025 | Uptravi, Opsumit |
| Bridgebio Pharma, INC. | $33.04 | 2025 | Attruby |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $30.33 | 2025 | |
| W. L. Gore & Associates, INC. | $26.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.60 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.44 | 2021 | |
| Mannkind Corporation | $16.05 | 2025 | |
| Ancora Heart, INC. | $14.28 | 2021 | |
| Cardiovascular Systems INC. | $6.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Stahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.